| VLDLR |
|---|
|
| Available structures |
|---|
| PDB | Ortholog search: PDBe RCSB |
|---|
|
|
| Identifiers |
|---|
| Aliases | VLDLR, CAMRQ1, CARMQ1, CHRMQ1, VLDLRCH, VLDL-R, very low density lipoprotein receptor |
|---|
| External IDs | OMIM: 192977; MGI: 98935; HomoloGene: 443; GeneCards: VLDLR; OMA:VLDLR - orthologs |
|---|
| Gene location (Human) |
|---|
| | Chr. | Chromosome 9 (human) |
|---|
| | Band | 9p24.2 | Start | 2,621,182 bp |
|---|
| End | 2,660,056 bp |
|---|
|
| Gene location (Mouse) |
|---|
| | Chr. | Chromosome 19 (mouse) |
|---|
| | Band | 19 C1|19 21.77 cM | Start | 27,216,484 bp |
|---|
| End | 27,254,231 bp |
|---|
|
| RNA expression pattern |
|---|
| Bgee | | Human | Mouse (ortholog) |
|---|
| Top expressed in | - right ventricle
- left ovary
- right ovary
- myocardium of left ventricle
- islet of Langerhans
- cardiac muscle tissue of right atrium
- right auricle of heart
- gingival epithelium
- biceps brachii
- body of pancreas
|
| | Top expressed in | - decidua
- retinal pigment epithelium
- ankle
- vas deferens
- right ventricle
- molar
- sternocleidomastoid muscle
- digastric muscle
- body of femur
- temporal muscle
|
| | More reference expression data |
|
|---|
| BioGPS | |
|---|
|
| Gene ontology |
|---|
| Molecular function | | | Cellular component | | | Biological process | | | Sources:Amigo / QuickGO |
|
|
| Wikidata |
|
The very-low-density-lipoprotein receptor (VLDLR) is a transmembrane lipoprotein receptor of the low-density-lipoprotein (LDL) receptor family. VLDLR shows considerable homology with the members of this lineage. Discovered in 1992 by Tokuo. Yamamoto and Sadao. Takahashi, VLDLR is widely distributed throughout the tissues of the body, including the heart, skeletal muscle, adipose tissue, and the brain, but is absent from the liver. This receptor has an important role in cholesterol uptake, metabolism of apolipoprotein E-containing triacylglycerol-rich lipoproteins, and neuronal migration in the developing brain. In humans, VLDLR is encoded by the VLDLR gene. Mutations of this gene may lead to a variety of symptoms and diseases, which include type I lissencephaly, cerebellar hypoplasia, and atherosclerosis.